FDA Approved: KANUMA — Supplemental Application (Alexion Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for KANUMA (sebelipase alfa) from Alexion Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lysosomal Acid Lipase Deficiency

Drugs mentioned

• KANUMA (Sebelipase alfa)

Snippet

SUPPL AP for KANUMA (SEBELIPASE ALFA)